Chargement en cours...
Asperpyrone A attenuates RANKL‐induced osteoclast formation through inhibiting NFATc1, Ca(2+) signalling and oxidative stress
Imbalance of osteoblast and osteoclast in adult leads to a variety of bone‐related diseases, including osteoporosis. Thus, suppressing the activity of osteoclastic bone resorption becomes the main therapeutic strategy for osteoporosis. Asperpyrone A is a natural compound isolated from Aspergillus ni...
Enregistré dans:
| Publié dans: | J Cell Mol Med |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850946/ https://ncbi.nlm.nih.gov/pubmed/31612613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14700 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|